Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001733085 XXXXXXXX LIVE 9 Common Stock, par value $0.0001 per share 04/09/2025 false 0001350653 02081G102 Alphatec Holdings, Inc. 1950 Camino Vida Roble Carlsbad CA 92008 Jeffrey Wade, c/o LS PD, LLC 212-547-2914 1700 Broadway 35th Floor New York NY 10019 0001733085 N L-5 Healthcare Partners, LLC WC N DE 0 7699315 0 7699315 7699315 N 5.3 OO Percentage of class in row (13) represented by amount in row (11) is based on a denominator consisting of 144,149,232 shares of Common Stock outstanding as reported in the Issuer's Form 10-K filed on February 25, 2025, together with 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer. Y Paul Segal OO N X1 0 7699315 0 7699315 7699315 N 5.3 IN Amounts shown in row 8 and row 10 represent 7,699,315 shares of Common Stock held by L-5 Healthcare Partners, LLC. Percentage of class in row (13) represented by amount in row (11) is based on a denominator consisting of 144,149,232 shares of Common Stock outstanding as reported in the Issuer's Form 10-K filed on February 25, 2025, together with 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer. Common Stock, par value $0.0001 per share Alphatec Holdings, Inc. 1950 Camino Vida Roble Carlsbad CA 92008 Item 5 of this Schedule 13D is hereby amended and restated in its entirety as follows: The information contained on the cover pages to this Schedule 13D is incorporated herein by reference. The aggregate percentage of Common Stock reported owned by each person named herein is based upon 144,149,232 shares of Common Stock outstanding as of February 19, 2025, which is the total number of shares of Common Stock outstanding as reported in the Issuer's Form 10-K filed with the Securities and Exchange Commission on February 25, 2025, together with 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer. L-5 directly holds 7,699,315 shares of Common Stock (which includes 6,556,155 shares of Common Stock and 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer) reported in this Schedule 13D. As a result of his relationship with L-5, Paul Segal may be deemed the beneficial owner of all such shares of Common Stock. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. The information set forth in Item (5)(a) of this Schedule 13D is incorporated by reference in its entirety into this Item 5(b). The transactions effected by the Reporting Persons during the past 60 days are set forth on Schedule 1 attached hereto. Not applicable. Not applicable. Schedule of Transactions for Item 5(c) of Amendment No. 9. L-5 Healthcare Partners, LLC /s/ Paul Segal Paul Segal, President 04/11/2025 Paul Segal /s/ Paul Segal Paul Segal 04/11/2025